Loading...
Every company here put through the same five checks on growth and cash generation. It describes the industry as it reports today — not which of these to buy.
| MCK | McKESSON CORPORATION | A | $127.3B | $1,102.73 | 28.40 | $418.8B | 1.1% |
| COR | CENCORA, INC. | A | $68.5B | $359.03 | 20.03 | $337.4B | 1.0% |
| CAH | Cardinal Health, Inc. | B | $65B | $281.14 | 38.89 | $254.2B | 0.7% |
| HSIC | HENRY SCHEIN, INC. | C | $9.5B | $86.23 | 23.62 | $13.7B | 3.1% |
| AHG | Akso Health Group | F- | $698.1M | $1.27 | — | $13.8M | -135.0% |
| COSM | COSMOS HEALTH INC. | F- | $326.1M | $3.24 | — | $73.7M | -33.1% |
| FOCL | EDAP TMS SA | B- | $155.4M | $3.29 | — | $87.5M | -42.8% |
| HKPD | Cellyan Biotechnology Co., Ltd | C- | $26.5M | $1.62 | — | $16.4M | -4.3% |
| YI | 111, Inc. | F | $24.1M | $2.78 | — | $1.6B | -1.0% |
| ACH | Accendra Health, Inc. | F | $10M | $0.13 | — | $2.6B | -6.7% |
| MEDS | DataMeds AI, Inc. | D | $4.2M | $0.74 | — | $7.7M | -564.8% |
Fundamentals from SEC filings, prices from the last market-data pass. Sort by any column; companies with no figure sort last either way.
Sorted by market cap, largest first; click any column to re-sort. Companies with no figure sort last either way, because a missing P/E means unprofitable rather than cheap. Nothing here is a recommendation.